Ovarian Cancer Embryology
Key points
- In the human embryo, the ovary appears as a genital ridge about 1 month after fertilization.
- The primitive mesoderm gives rise to the mesothelial covering of the ovary and of the peritoneum, the so-called germinal epithelium from which epithelial ovarian cancers and primary peritoneal cancers are thought to arise.
- These cells arise along the medial and ventral borders of the mesonephros from which the mesenchymal tissues of the ovary are derived.
- The mesenchymal tissues give rise to the ovarian stroma.
In the human embryo, the ovary appears as a genital ridge about 1 month after fertilization. The primitive mesoderm gives rise to the mesothelial covering of the ovary and of the peritoneum, the so-called germinal epithelium from which epithelial ovarian cancers and primary peritoneal cancers are thought to arise. These cells arise along the medial and ventral borders of the mesonephros from which the mesenchymal tissues of the ovary are derived. The mesenchymal tissues give rise to the ovarian stroma. The germ cells originate from the primitive streak and migrate from the yolk sac endoderm toward the developing ovary. The primitive ovary is histologically unique and distinguishable from the primitive testis by 6 weeks after fertilization. The ovarian cortex develops by 8 to 9 weeks.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsSurviving Ovarian Cancer: Rutgers Scientists Attack Drug Resistant Cancer Cells
Scientists at Rutgers University have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates for the most deadly gynecological cancer in the…
10 December 2013
NewsNanotech system, cellular heating may improve treatment of ovarian cancer
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs,…
18 October 2013
NewsFemale hormones key to breast and ovarian cancer in BRCA gene carriers
Researchers announced today in the journal Lancet Oncology that they are well on the way to discovering why women with the faulty genes BRCA 1 and BRCA 2, one of which was inherited by the actress Angelina Jolie,…
